Skip to content

Study of the Treatment of Burn Wounds With Antimicrobial Topical Soaks

Comparing the Use of Sulfamylon 5%, Dakins 0.025%, Cerium, Silver Nitrate 5% and/or Other Topical Antimicrobial Products for the Treatment of Excised and/or Grafted Burn Wounds

Status
Terminated
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00675922
Acronym
Soaks
Enrollment
98
Registered
2008-05-12
Start date
1995-07-31
Completion date
2008-05-31
Last updated
2023-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn

Keywords

Burn, Wounds, Wound infection, Topical antimicrobials, Cerium, Dakins, Sulfamylon Soaks, Silver Nitrate

Brief summary

Determine effectiveness of various antimicrobial solutions on burn wounds (infections, wound healing, length of hospital stay).

Detailed description

Patients were treated with both Sulfamylon soaks and Silver nitrate soaks on different burn areas. These two areas were then compared for incidence (percentage) of infections.

Interventions

DRUGSulfamylon 5% and Silver Nitrate Soaks

Application of Sulfamylon and Silver Nitrate Solution to burn wound daily

Sponsors

The University of Texas Medical Branch, Galveston
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 90 Years
Healthy volunteers
No

Inclusion criteria

* Burn Injury requiring excisional therapy * Hospitalization required until wounds are closed

Exclusion criteria

* Known hypersensitivity to products * Outpatient treatment for burn injury

Design outcomes

Primary

MeasureTime frameDescription
Infection RateAcute hospitalization following burn injury: admission to discharge (1-20 weeks)Percent of infections following antimicrobial topical treatment with Sulfamylon vs Silver Nitrate Soaks.

Secondary

MeasureTime frameDescription
Length of Hospital Stay With Various Antimicrobial Solutions for Burn PatientsAdmission to burn unit to dischargeAt the request of the study site, this study has been closed. Access to study-related data is unavailable, and the PI is no longer at the institution. Hence, we are unable to submit the results data for this outcome. Although peer-reviewed articles have been located that reference NCT00675922 it is not clear and verifiable (without access to the actual study-related data) what the results for this outcome.

Countries

United States

Participant flow

Recruitment details

Patients admitted to Burn ICU with acute burn injury were eligible for recruitment

Pre-assignment details

Patients consented were randomized to one or two of the treatment medications.

Participants by arm

ArmCount
Sulfamylon vs Silver Nitrate Solution
Application of Sulfamylon 5% and Silver Nitrate Solution soaked dressings to a burned area
98
Total98

Baseline characteristics

CharacteristicSulfamylon vs Silver Nitrate Solution
Age, Categorical
<=18 years
86 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
12 Participants
Sex: Female, Male
Female
32 Participants
Sex: Female, Male
Male
66 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
2 / 98
serious
Total, serious adverse events
9 / 98

Outcome results

Primary

Infection Rate

Percent of infections following antimicrobial topical treatment with Sulfamylon vs Silver Nitrate Soaks.

Time frame: Acute hospitalization following burn injury: admission to discharge (1-20 weeks)

Population: Percent of sites treated with sulfamylon of Silver Nitrate soaks that developed infections

ArmMeasureValue (NUMBER)Dispersion
Percent Infections:Sulfamylon SiteInfection Rate72 percentage of participants 0.05
Percent Infections: Silver Nitrate SiteInfection Rate74 percentage of participants
Secondary

Length of Hospital Stay With Various Antimicrobial Solutions for Burn Patients

At the request of the study site, this study has been closed. Access to study-related data is unavailable, and the PI is no longer at the institution. Hence, we are unable to submit the results data for this outcome. Although peer-reviewed articles have been located that reference NCT00675922 it is not clear and verifiable (without access to the actual study-related data) what the results for this outcome.

Time frame: Admission to burn unit to discharge

Population: At the request of the study site, this study has been closed. Access to study-related data is unavailable, and the PI is no longer at the institution. Hence, we are unable to submit the results data for this outcome. Although peer-reviewed articles have been located that reference NCT00675922 it is not clear and verifiable (without access to the actual study-related data) what the results for this outcome.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026